Because of price discrimination, Europeans pay much more for GlaxoSmithKline's (GSK) AIDS drug Combivir than do Africans. If price discrimination were outlawed, and GSK had to choose one price for both markets, this could: benefit Europeans, because GSK might choose a world price that is higher than the African price. harm Europeans, because GSK might choose a world price that is higher than the European price. benefit Europeans, because GSK might choose a world price that is lower than the African price. benefit Europeans, because GSK might choose a world price that is lower than the European price